Noninvasive Assessment of Left Ventricular Structure and Function in Patients with End-Stage Renal Disease

2015 ◽  
pp. 13-25 ◽  
Author(s):  
Martin A. Alpert ◽  
Volker Wizemann ◽  
J�rgen H�ting ◽  
Clara V. Massey
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Structure And Function ◽  
Left Ventricular Structure ◽  
Ventricular Structure ◽  
Noninvasive Assessment ◽  
Stage Renal Disease ◽  
End Stage ◽  
And Function

Aging and Left Ventricular Mass and Function in People with End-Stage Renal Disease

2011 ◽  
Vol 59 (9) ◽  
pp. 1636-1641 ◽  
Author(s):  
Giovanni Tripepi ◽  
Francesco Mattace-Raso ◽  
Eric Sijbrands ◽  
Jacqueline Witteman ◽  
Francesco Rapisarda ◽  
...  
Keyword(s):  
Renal Disease ◽  
Left Ventricular Mass ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Ventricular Mass ◽  
Stage Renal Disease ◽  
End Stage ◽  
And Function

scholarly journals 3D Echocardiography – A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease Patients

2021 ◽  
pp. S109-S120
Author(s):  
M. Kovářová ◽  
Z. Žilinská ◽  
J. Páleš ◽  
Z. Kužmová ◽  
A. Gažová ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Structure And Function ◽  
2D Echocardiography ◽  
Diastolic Velocity ◽  
Stage Renal Disease ◽  
End Stage ◽  
And Function ◽  
Esrd Patients

Patients with chronic kidney disease (CKD) have an increased risk of premature mortality, mainly due to cardiovascular causes. The association between hemodialysis and accelerated atherosclerosis has long been described. The ankle-brachial index (ABI) is a surrogate marker of atherosclerosis and recent studies indicate its utility as a predictor of future cardiovascular disease and all-cause mortality. The clinical implications of ABI cut-points are not well defined in patients with CKD. Echocardiography is the most widely used imaging method for cardiac evaluation. Structural and functional myocardial abnormalities are common in patients with CKD due to pressure and volume overload as well as non-hemodynamic factors associated with CKD. Our study aimed to identify markers of subclinical cardiovascular risk assessed using ABI and 2D and 3D echocardiographic parameters evaluating left ventricular (LV) structure and function in patients with end-stage renal disease (ESRD) (patients undergoing dialysis), patients after kidney transplantation and non-ESRD patients (control). In ESRD, particularly in hemodialysis patients, changes in cardiac structure, rather than function, seems to be more pronounced. 3D echocardiography appears to be more sensitive than 2D echocardiography in the assessment of myocardial structure and function in CKD patients. Particularly 3D derived end-diastolic volume and 3D derived LV mass indexed for body surface appears to deteriorate in dialyzed and transplanted patients. In 2D echocardiography, myocardial mass represented by left ventricular mass/body surface area index (LVMI) appears to be a more sensitive marker of cardiac structural changes, compared to relative wall thickness (RWT), left ventricle and diastolic diameter index (LVEDDI) and left atrial volume index (LAVI). We observed a generally favorable impact of kidney transplantation on cardiac structure and function; however, the differences were non-significant. The improvement seems to be more pronounced in cardiac function parameters, peak early diastolic velocity/average peak early diastolic velocity of mitral valve annulus (E/e´), 3D left ventricle ejection fraction (LV EF) and global longitudinal strain (GLS). We conclude that ABI is not an appropriate screening test to determine the cardiovascular risk in patients with ESRD.

Sign in / Sign up

Export Citation Format

Share Document